Detailed Information
Cited 7 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Randomized, phase II trial to evaluate the efficacy and safety of atezolizumab plus capecitabine adjuvant therapy compared to capecitabine monotherapy for triple receptor-negative breast cancer (TNBC) with residual invasive cancer after neoadjuvant chemotherapy (MIRINAE trial, KCSG-BR18-21).
- Authors
- Park, In Hae; Kim, Gun Min; Kim, Jee Hyun; Kim, Hanjo; Park, Kyong Hwa; Park, Yeon Hee; Baek, Sun Kyung; Sim, Sung Hoon; Ahn, Hee Kyung; Lee, Gyeong-Won; Lee, Kyoung Eun; Lee, Ji Eun; Lim, Seungtaek; Jung, Kyung Hae; Im, Seock-Ah
- Issue Date
- 20-May-2020
- Publisher
- American Society of Clinical Oncology
- Citation
- Journal of Clinical Oncology, v.38, no.15
- Indexed
- SCIE
SCOPUS
- Journal Title
- Journal of Clinical Oncology
- Volume
- 38
- Number
- 15
- ISSN
- 0732-183X
1527-7755
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medicine > Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.